September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Relative susceptibility of individual neuron classes to different insults in rat retinal cultures
Author Affiliations & Notes
  • John P M Wood
    Department of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Department of Ophthalmology, Unversity of Adelaide, Adelaide, South Australia, Australia
  • Glyn Chidlow
    Department of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Department of Ophthalmology, Unversity of Adelaide, Adelaide, South Australia, Australia
  • Robert James Casson
    Department of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Department of Ophthalmology, Unversity of Adelaide, Adelaide, South Australia, Australia
  • Footnotes
    Commercial Relationships   John Wood, None; Glyn Chidlow, None; Robert Casson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 753. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John P M Wood, Glyn Chidlow, Robert James Casson; Relative susceptibility of individual neuron classes to different insults in rat retinal cultures. Invest. Ophthalmol. Vis. Sci. 2016;57(12):753.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the relative susceptibility of different classes of cultured retinal neuron to distinct insults: metabolic compromise, excitotoxicity and oxidative stress.

Methods : Retinal cultures were prepared from neonatal rat pups via a mechanical and enzymatic digest; cultures were allowed to grow for 7 days before treatment and each treatment lasted 16 hours. Neurons were classified according to immunolabelling for combinations of discrete markers (GABA, tau, βIII-tubulin, MAP2, calretinin, syntaxin, PGP9.5, synaptophysin, NeuN). Cells were treated with sodium azide (NaN3; 500µM) to simulate metabolic compromise, kainic acid (KA; 50µM) to induce excitotoxicity or t-butyl hydroperoxide (t-bH; 1µM) to bring about oxidative stress. After treatments, surviving cells were quantified by immunocytochemistry, Western blot or the absence of apoptosis (TUNEL); cell loss for analysed markers was quantified in each case either by cell/protein quantification or by using ImageJ, where appropriate.

Results : All neurons in the cultures (except for photoreceptors) labelled positively for tau; 35±5% of tau-positive neurons remained after treatment with KA, 53±7% after treatment with t-bH and 19±4% after treatment with NaN3. Different subsets of the tau-positive neurons labelled with combinations of GABA, βIII-tubulin, MAP2, syntaxin, PGP9.5, synaptophysin or NeuN; interestingly, tau/calretinin neurons did not label with any other marker. GABA/tau- and calretinin/tau-labelled neurons were the most susceptible to KA, being reduced to 5±3% and 13±5% of control values respectively; syntaxin/tau neurons were the least susceptible, with 43±11% remaining after insult. PGP9.5/tau neurons were the most affected by NaN3 with just 8±5% remaining after treatment; syntaxin/tau neurons were the least affected (72±7% remaining). Calretinin/tau neurons were the most susceptible to t-bH (14±6% remaining after treatment); βIII-tubulin/tau neurons were the least susceptible (68±8% remaining).

Conclusions : Cultured retinal neurons display differential susceptibilities to both specific (excitotoxic, KA) and to more general (oxidative stress, t-bH; metabolic compromise, NaN3) toxic agents. Translation of the present data to the in vivo situation may allow predictions of specific retinal neuron class susceptibility to specific injurious situations and diseases.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×